Health Inc. : Shots - Health NewsAs spending on care rises, the business of health keeps getting more important. We feature news on and analysis of drugmakers, health insurers, hospitals, doctors and others in the business of providing health care.
The Senate health committee meets next month to discuss ways to stabilize the insurance markets. Insurers have until Sept. 27 to commit to selling policies on the ACA marketplaces in 2018.
Andrew Harnik/AP
hide caption
A California jury awarded a woman $417 million in a case against Johnson & Johnson. The woman claimed that her use of Johnson's Baby Powder led to terminal ovarian cancer. Scientists disagree on how strong a link there is between talc and ovarian cancer.
Frederic J. Brown/AFP/Getty Images
hide caption
About 50 percent of patients don't take their medicine as prescribed, research shows. And those mistakes are thought to result in at least 100,000 preventable deaths each year.
amphotora/Getty Images
hide caption
Dillon Katz, at home in Delray Beach, Fla., says recovering drug users in his group counseling meetings frequently used to offer to help him get into a new treatment facility. He suspects now they were recruiters — so-called "body brokers" — who were receiving illegal kickbacks from the corrupt facility.
Peter Haden/WLRN
hide caption
A recent study shows a link between high discharge rates for live patients and hospice profit margins.
Gary Waters/Getty Images/Ikon Images
hide caption
Andrew Ladd and Fumiko Chino at their wedding in 2006, after his cancer diagnosis. Ladd died the following year, leaving behind hundreds of thousands of dollars in medical debt.
Courtesy of Dr. Fumiko Chino
hide caption
Valeant Pharmaceuticals, based in Bridgewater Township, N.J., bought two specialty heart drugs used in emergency treatment from Marathon Pharmaceuticals in 2015, and then dramatically increased each drug's price.
Ron Antonelli/Bloomberg via Getty Images
hide caption
Vicki Reid, right, holds a likeness of John Martin, who was then CEO of the pharmaceutical company Gilead Sciences. Reid and others were protesting high drug prices in front of the conference on retroviruses and opportunistic infections — a meeting held at the World Congress Center in Atlanta in March 2013.
John Amis/AP Images for AIDS Healthcare Foundation
hide caption
toggle caption
John Amis/AP Images for AIDS Healthcare Foundation